Soru

Zorluk: ZorOrdering Laboratory Tests

A 62-year-old man is evaluated in the hospital on postoperative day 7 following a coronary artery bypass grafting. He has been recovering well and is scheduled for discharge to a cardiac rehabilitation facility in two days. His daily medications include aspirin, atorvastatin, metoprolol, and subcutaneous unfractionated heparin for venous thromboembolism prophylaxis. Today, his vital signs are temperature 37.0°C (98.6°F), blood pressure 128/78 mmHg, pulse 76/min, and respirations 14/min. Physical examination reveals a clean, healing sternal incision, clear lung fields, and normal heart sounds. There is no lower extremity edema, erythema, or tenderness. Routine morning laboratory results show:

Hemoglobin: 11.2 g/dL
Leukocyte count: 8,500/mm³
Platelet count: 85,000/mm³ (baseline on admission was 210,000/mm³)
Creatinine: 1.1 mg/dL

Which of the following is the most appropriate next step in laboratory evaluation?

  1. A
    Serotonin release assay
  2. B
    Prothrombin time and activated partial thromboplastin time
  3. Immunoassay for platelet factor 4-heparin antibodiesCevap
  4. D
    Peripheral blood smear
  5. E
    Factor V Leiden mutation analysis

Cevap

Immunoassay for platelet factor 4-heparin antibodies
The correct next step is to order an immunoassay for platelet factor 4 (PF4)-heparin antibodies. This patient's clinical picture is classic for heparin-induced thrombocytopenia (HIT) type 2. HIT typically presents 5 to 10 days after the initiation of heparin therapy with a platelet count drop of greater than 50% from baseline. The patient's 4T score (Thrombocytopenia, Timing, Thrombosis, oTher causes) is high (6 points). Guidelines mandate that for patients with an intermediate or high 4T score, all heparin products must be stopped, a non-heparin anticoagulant (e.g., argatroban, bivalirudin, fondaparinux) should be started, and diagnostic laboratory testing should be initiated. The first diagnostic step is the PF4-heparin antibody ELISA, which is highly sensitive. If this is positive, the diagnosis is confirmed using a highly specific functional assay, such as the serotonin release assay.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation and laboratory timeline.
The patient is on post-op day 7 receiving unfractionated heparin and has experienced an asymptomatic drop in platelets from 210,000/mm³ to 85,000/mm³ (a >50% decrease).
Identifying the timing and magnitude of thrombocytopenia relative to drug exposure is critical for calculating the pretest probability of heparin-induced thrombocytopenia (HIT).
2
Determine the 4T score for this patient.
The score is high: Thrombocytopenia (>50% drop) = 2 points; Timing (days 5-10) = 2 points; Thrombosis (none yet) = 0 points; oTher causes (none apparent) = 2 points. Total = 6 (High probability).
A high 4T score mandates immediate cessation of heparin, initiation of a non-heparin anticoagulant, and diagnostic laboratory testing.
3
Select the appropriate initial laboratory test for the suspected diagnosis.
An immunoassay (ELISA) for platelet factor 4 (PF4)-heparin antibodies is the most sensitive initial screening test.
Screening tests should have high sensitivity. Confirmatory tests (like the serotonin release assay) have higher specificity but are reserved for patients with a positive screening ELISA.

Anahtar Kavram

Patients with a moderate to high pretest probability (4T score) for heparin-induced thrombocytopenia should be evaluated initially with an immunoassay for platelet factor 4-heparin antibodies, followed by a serotonin release assay only if the initial screen is positive.
Bu soruyu puanla